-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $112

Benzinga·07/17/2026 14:28:10
語音播報
Wells Fargo analyst Larry Biegelsen maintains Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $109 to $112.